Tag Archives: Patent Reform

USPTO Issues New Myriad Guidance

Kaylee_dna_115x76

On Tuesday, December 16 the United States Patent and Trademark Office issued a revised guidance on subject matter eligibility under § 101 in light of recent Supreme Court Decisions in Alice v. CLS Bank, Mayo, and Myriad. These new guidelines are a response to extensive feedback provided from industry leaders and inventors over the last several months. (BIO provided both initial and supplemental comments on the Office’s March Subject Matter Eligibility Guidance). Public comments on the Read More >

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , , , , , , , ,

Patently Biotech’s Top Articles of 2014

shutterstock_26191726

It’s been a whirlwind year for IP. From international trade negotiations, to revised PTO guidelines and dropping patent case stats, intellectual property is on the brain and in the news. Here are Patently Biotech’s top blog posts of 2014: TPP and IP: The Economic Benefits of a Pacific Trade Agreement Should the USPTO allow the patenting of living organisms? Gene Patent Questions Remain: USPTO Issues Examiner Guidelines Stopped at the Threshold: A New Study Reports Read More >

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , ,

BIO Coalition Submits Patent Reform Letter to Congress

medical_research

BIO, alongside a coalition of patent holders and inventors, submitted a letter to the chairmen and ranking members of the House and Senate Judiciary Committees on December 10 regarding potential changes to the patent system. The coalition thanked members of the committee for their work to develop reforms which would prevent harmful patent enforcement practices, and once again reiterated their opposition to any legislation that would weaken the overall patent system. They also asked that Read More >

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , , , , , , , , , , , , , ,

Patent Trolls and Nigerian Scammers

admin-ajax (1)

What do patent trolls and Nigerian princes have in common? Two things come to mind. First, if you get an email from either one, nothing good can come from it. Second, hardly anybody falls for either scam. According to the Federal Trade Commission (FTC), the most notorious patent assertion entity (otherwise known as a patent troll) has agreed to a consent decree. Which means they have agreed to halt their deceptive business practices. Of course, Read More >

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: , , , , ,

Need for Patent Reform May be Overblown

admin-ajax

Amid the cacophony of calls for patent reform legislation, mounting evidence demonstrates patent trolling may be on the wane. As we reported earlier this month, the number of new patent cases filed in federal court has dropped by an astonishing 40 percent as compared to this time last year. A new data analysis by Unified Patents data shows more signs that patent troll suits are in decline.

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: , , ,